Literature DB >> 17981731

HGF and c-MET as potential orchestrators of invasive growth in head and neck squamous cell carcinoma.

Maria-Jantine De Herdt1, Robert J Baatenburg de Jong.   

Abstract

Head and neck squamous cell carcinoma (HNSCC) constitutes 90% of all head and neck cancers and is associated with high mortality rates, due to the high infiltrative potential of these tumors. Despite advances in treatment approaches, there has been no improvement in survival rates. As empiricism in the treatment of HNSCC is unlikely to improve the prognosis of HNSCC patients, understanding the pathogenesis behind the local invasion of these tumors on the cellular and molecular levels has become an important goal in the field of head and neck surgery. It is believed that the invasive growth of neoplastic cells is a deregulated form of the physiological program that occurs during the formation and patterning of an embryo, which is largely facilitated by HGF induced signaling through its receptor c-MET. This review investigates whether HGF and c-MET are deregulated in HNSCC and whether they confer an invasive potential to these tumors. It is concluded that both molecules are mis- and over-expressed in HNSCC and probably induce the program of invasive growth in HNSCC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17981731     DOI: 10.2741/2863

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  22 in total

1.  Head and neck squamous cell carcinoma in pregnant women.

Authors:  Anna M Eliassen; Samantha J Hauff; Alice L Tang; Dafydd H Thomas; Jonathan B McHugh; Heather M Walline; Jay Stoerker; Jessica H Maxwell; Francis P Worden; Avraham Eisbruch; Michael J Czerwinski; Silvana M Papagerakis; Douglas B Chepeha; Carol R Bradford; David A Hanauer; Thomas E Carey; Mark E Prince
Journal:  Head Neck       Date:  2012-03-16       Impact factor: 3.147

Review 2.  Targeted therapy in head and neck cancer.

Authors:  S K Kundu; M Nestor
Journal:  Tumour Biol       Date:  2012-02-29

3.  Regulation of cell migration via the EGFR signaling pathway in oral squamous cell carcinoma cells.

Authors:  Yuichi Ohnishi; Hiroki Yasui; Kenji Kakudo; Masami Nozaki
Journal:  Oncol Lett       Date:  2016-12-14       Impact factor: 2.967

4.  Receptor-type Protein tyrosine phosphatase β regulates met phosphorylation and function in head and neck squamous cell carcinoma.

Authors:  Yiru Xu; Jin Zhou; Thomas E Carey; Jonathan B McHugh; John J Voorhees; Gary J Fisher
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

5.  HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer.

Authors:  Lynn M Knowles; Laura P Stabile; Ann Marie Egloff; Mary E Rothstein; Sufi M Thomas; Christopher T Gubish; Edwina C Lerner; Raja R Seethala; Shinsuke Suzuki; Kelly M Quesnelle; Sarah Morgan; Robert L Ferris; Jennifer R Grandis; Jill M Siegfried
Journal:  Clin Cancer Res       Date:  2009-05-26       Impact factor: 12.531

6.  Silencing Met receptor tyrosine kinase signaling decreased oral tumor growth and increased survival of nude mice.

Authors:  X Tao; K S Hill; I Gaziova; S K Sastry; S Qui; P Szaniszlo; S Fennewald; V A Resto; L A Elferink
Journal:  Oral Oncol       Date:  2013-11-21       Impact factor: 5.337

7.  Detection of MET and SOX2 amplification by quantitative real-time PCR in non-small cell lung carcinoma.

Authors:  Yi-Ran Cai; Hai-Qing Zhang; Zong-DE Zhang; Jing Mu; Zi-Hui Li
Journal:  Oncol Lett       Date:  2010-12-23       Impact factor: 2.967

8.  Enhancement of head and neck squamous cell carcinoma proliferation, invasion, and metastasis by tumor-associated fibroblasts in preclinical models.

Authors:  Sarah Elizabeth Wheeler; Huifang Shi; Fangchen Lin; Sumana Dasari; Joseph Bednash; Stephen Thorne; Simon Watkins; Radhika Joshi; Sufi Mary Thomas
Journal:  Head Neck       Date:  2013-06-01       Impact factor: 3.147

Review 9.  Stem-like cells and therapy resistance in squamous cell carcinomas.

Authors:  Nicole Facompre; Hiroshi Nakagawa; Meenhard Herlyn; Devraj Basu
Journal:  Adv Pharmacol       Date:  2012

10.  MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer.

Authors:  George Fountzilas; Anna Kalogera-Fountzila; Sophia Lambaki; Ralph M Wirtz; Angelos Nikolaou; Georgia Karayannopoulou; Mattheos Bobos; Vassiliki Kotoula; Samuel Murray; Alexandros Lambropoulos; Gerasimos Aravantinos; Konstantinos Markou; Eleni Athanassiou; Despina Misailidou; Konstantine T Kalogeras; Demosthenis Skarlos
Journal:  J Oncol       Date:  2009-12-29       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.